Alpine Immune Sciences

$12.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.41 (-3.12%) Today

$0.00 (0.00%) As of 12:18 PM UTC after-hours

Why Robinhood?

You can buy or sell ALPN and other stocks, options, and ETFs commission-free!

About ALPN

Alpine Immune Sciences, Inc. Common Stock, also called Alpine Immune Sciences, is a development-stage pharmaceutical company. The firm engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA. The listed name for ALPN is Alpine Immune Sciences, Inc. Common Stock.

CEO

Mitchell H. Gold

Employees

Headquarters

Seattle, Washington

Founded

2015

Market Cap

306.46M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

128.49K

High Today

$13.46

Low Today

$12.35

Open Price

$13.20

Volume

118.71K

52 Week High

$16.37

52 Week Low

$2.05

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

ALPN Earnings

-$0.68

-$0.45

-$0.23

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 30, After Hours